◀ Back to MMP14

CSN3 — MMP14

Text-mined interactions from Literome

Lee et al., Curr Med Chem 2001 (Fibrosarcoma...) : This MT1-MMP preparation exhibited ( i ) pro-MMP-2 activating activity as shown by molecular weight shift of this gelatinase from 72 kDa to 62 kDa using gelatin zymography, and ( ii ) the ability to degrade both [ ( 3 ) H-methyl ] gelatin and casein at 37 degrees C. Adding CMT-3 at final concentrations of 5 -- 20microM inhibited MT1-MMP gelatinolytic and caseinolytic activity, blocked MT1-MMP activation of pro-MMP-2, and decreased invasiveness ( using the Matrigel system ) of HT-1080 fibrosarcoma cells
Liebetrau et al., Neurosci Lett 2005 (Disease Models, Animal...) : Brain tissue plasminogen activator (t-PA) and urokinase ( u-PA ) were quantified by using casein dependent plasminogen zymography, matrix metalloproteinase (MMP)-2 and MMP-9, by MMP-zymography, and tissue inhibitor of MMP (TIMP)-1 and -2, by reverse zymography